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1. Introduction
  Tecomaria capensis (T. capensis) Thunb. (Bignoniaceae), 
also known as Cape-honeysuckle a fast growing, scrambling 
shrub which may grow up to 2-3 m high and spread more 
than 2.5 m. T. capensis is an evergreen plant in warm 
climate areas but loses its leaves in colder areas. It has 
pinnately compound leaves that have oval leaflets with 
blunt teeth. Flowering time for this shrub is very erratic and 
often it flowers all year round. Flowers are orange in color. 
Flowers are tubular and bird pollinated, attracting nectar-
feeding birds, especially sunbirds. The powdered bark of 
this plant is used as a traditional medicine to relieve pain 
and sleeplessness[1]. Dried powdered bark infusions are 
taken for sleeplessness[2] and are reported to induce sleep[3]. 
It is included in the list of African plants evaluated for in 
vitro antiplasmodial activity against Plasmodium falciparum 
(P. falciparum)[4].
  The present study was carried out to determine the effect 
of methanolic extract of T. capensis leaves (TCLE) on wound 
healing based on two evidence, (1) Previously methanol 
extract of T. capensis leaves reported as antimicrobial[5] and 
antioxidant[6]; (2) Phytochemical investigation of methanol 
extract of T. capensis leaves revealed the presence of 
triterpenoids, phenolics, glycosides, flavonoids. 
  It is well known that certain flavonoids exhibit 
hypoglycemic activity[7,8] and are also known for their 
ability of beta cell regeneration of pancreas[9,10].
2. Materials and methods
2.1. Plant material
  The leaves of T. capensis Thunb. (Bignoniaceae) were 
collected from Jaipur National University, Jaipur, Rajasthan, 
India on 1 July, 2010. The plant was identified by the Mr. 
Vinod Sharma, Herbarium Head, Department of Botany, 
Rajasthan University, Jaipur.  A voucher specimen 
(RUBL 20847) for this plant material was preserved in the 
herbarium of Department of Botany, Rajasthan University, 
Jaipur, Rajasthan, India.  The leaves, dried in shade were 
powdered and subjected to soxhlet extraction with methanol 
at 40-60 曟 for 72 h. The extract collected was evaporated 
(yield 26.7%. w/w), and stored in a vacuum desiccator. 
The preliminary phytochemical investigations with the 
methanolic extract revealed the presence of flavonoids, 
flavones, phenolic compound, tannins, volatile oil, fixed oil, 
steroids, saponins, glycosides[11-13]. 
Objective: To evaluate the antihyperglycemic activity of Tecomaria capensis (T. capensis) Thunb. 
(Bignoniaceae) methanolic leaves extract (TCLE) using blood glucose level in normal fasted rats, 
glucose tolerance test and alloxan induced hyperglycemia models. Methods: TCLE (100, 300, 
1 000 and 2 000 mg/kg body wt.) was given to rats orally to observe acute toxicity, and observed 
for 14 d. TCLE 200 and 400 mg/kg, and glibenclamide 0.6 mg/kg were given orally in all models. 
Results: Results demonstrated that the no mortality was reported even after 14 d. This indicates 
that the methanol extract is safe up to a single dose of 2 000 mg/kg body weight. TCLE (200 and 
400 mg/kg p.o.) exhibited remarkable blood glucose lowering effect in blood glucose level in 
normal fasted rats, glucose tolerance and alloxan induced hyperglycemia model. Cholesterol and 
triglyceride also decreased in alloxan induced hyperglycemia model. Conclusions: The results of 
this study exhibites that methanol extract of T. capensis possesses antihypergycemic activity and 
it may prove to be effective for the treatment of hyperglycemia.
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2.2. Drugs and chemical
  The following drugs and chemical namely, glibenclamide, 
Alloxan, glucose and EDTA were used during the 
experimental study.
2.3. Animals
  Albino rats of either sex (150-200 g) were used for the 
experimental study. The animals were maintained under 
standard husbandry conditions in polypropylene cages and 
provided with food and water ad libitum. The animals were 
kept on fasting overnight prior to the experimentation and 
all the procedures used in these studies were approved by 
the Institutional Animal Ethics Committee.
2.4. Acute toxicity studies
  The acute toxicity was performed according to OECD 
guideline[14]. The selected female albino rats were used for 
toxicity studies. The animals were divided into four groups 
of three in each. The animals were fasted overnight prior to 
the acute experimental procedure. Extract was given orally to 
rats at the graded doses like 100, 300, 1 000 and 2 000 mg/kg
body wt. Immediately, after dosing, the animals were 
observed continuously for first four hours for behavioral 
changes and for mortality at the end of 24 h, and daily for 14 d
for any behavioural change or mortality.
2.5. Blood glucose level in normal fasted rats
  Four randomized groups six in each of normal fasted rats 
were administered 200 and 400 mg/kg of the TCLE, 0.6 mg/kg
of glibenclamide and vehicle orally. Subsequently, blood 
sugar levels were assessed at 1, 2 and 3 h intervals[15].
2.6. Glucose tolerance test
  Four groups of 6 rats each were used for the study. 
Group 1 served as normal Vehicle, Group 2 animals were 
administered with 0.6 mg/kg of glibenclamide orally, Group 
3 animals were administered with TCLE 200 mg/kg orally and 
Group 4 animals were administered with TCLE 400 mg/kg
orally. The rats of all the groups were loaded with 60% 
glucose (3 g/kg p.o.) 30 min after extract administration. 
Blood sugar levels were assessed at 1, 2 and 3 h intervals[16].
2.7. Alloxan induced hyperglycemia
  Induction of hyperglycemia: alloxan 150 mg/kg was 
administered i.p. following which glucose was added to the 
drinking water of the animals to prevent hypoglycemic crisis. 
Fasting blood sugar (FBS) for the animals was measured after 
72 h. Animals with FBS level ≥ 300 mg/dL were considered 
hyperglycemic[17].
  The animals showing hyperglycemia were then grouped in 
4 groups of 6 animals each. Group 1 received vehicle. Group 
2 were administered with glibenclamide 0.6 mg/kg orally, 
Group 3 animals were administered with TCLE 200 mg/kg 
orally and Group 4 animals were administered with TCLE 
400 mg/kg orally. Blood samples were obtained at 2, 4 and 6 
h after treatment[18].
  For repeated dose treatment animals were treated once a 
day for 14 d and were given free access to food and water ad 
libitum. On the 15th day animals were killed by decapitation 
and blood was collected from the arterial jugular and serum 
was separated. The serum was used for the estimation of 
various biochemical parameters including blood glucose 
level, cholesterol level and triglyceride level[19].
2.8. Method of blood collection and glucose, cholesterol and 
triglyceride estimation
  Blood samples were collected from the retro-orbital 
puncture. Blood glucose level was determined by using 
glucometer (one touch ultra). Cholesterol and triglyceride 
level were determined by using commercial kit for 
cholesterol and triglyceride estimation.
   
2.9. Statistical analysis 
  Results are expressed as mean依S.E.M. Statistical 
significance was determined by using the one way ANOVA 
followed by Dunnett’s multiple comparison test. P < 0.05 was 
considered statistically significant.
3. Results
3.1. Acute toxicity studies
  In toxicity study four groups of rats were administered 
with methanolic T. capensis leaves extract in graded doses 
of 100 mg/kg, 300 mg/kg, 1 000 mg/kg and 2 000 mg/kg p.o., 
respectively. The animals were kept under observation 
for the change in behavior or death up to 14 d following 
the plant extract administration. The extract administration 
neither caused any significant change in the behaviors nor the 
death of animal(s) in all the test groups. This indicates that 
the methanol extract is safe up to a single dose of 2 000 mg/kg
body weight. Hence we have selected 200 to 400 mg/kg
oral doses of methanolic T. capensis leaves extract to 
evaluate different pharmacological activity in rats.
Table 1
Effect of TCLE on fasting blood glucose level in normal rats.
Treatment groups
Glucose concentration at different time interval  (mg/dL)
0 h 1 h 2 h 3 h
Control 60.33依1.10 63.50依2.14 62.67依2.65 61.50依1.71
Glibenclamide 64.33依2.75 56.67依2.01   51.83依1.68**     46.67依2.01***
TCLE 200 mg/kg 65.17依3.12 58.50依2.71 55.50依1.86   53.17依0.91*
TCLE 400 mg/kg 70.17依2.47 63.00依2.54 58.83依2.43    55.83依2.37*
Values are expressed as mean依S.E.M.  (n=6). *P<0.05, **P<0.01, ***P<0.001 as compared to control. One way anova followed by Dunnett’s 
multiple comparison test.
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3.2. Blood glucose level in normal fasted rats
  Fasting blood glucose test in normal rats revealed that 
TCLE given at 200 mg/kg and 400 mg/kg produced a 
significant fall in blood glucose (compared to the initial 
level) 3 h after administration (Table 1), though the effect 
was less than that produced by glibenclamide 0.6 mg/kg p.o.
3.3. Glucose tolerance test
  The TCLE 200 mg/kg, TCLE 400 mg/kg and glibenclamide 
p.o. exhibited remarkable blood glucose lowering effect in 
the glucose tolerance test (Figure 1) compare to control. The 
TCLE 200 mg/kg and 400 mg/kg inhibit glucose increase 31% 
and 34.5% respectively, and glibenclamide 0.6 mg/kg p.o. 
inhibit glucose increase 34.18% compare to control at 1 h. 
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Figure 1. Effect of TCLE on blood glucose level in glucose tolerance 
test.
Values are expressed as mean依S.E.M.  (n=6). *P<0.05, **P<0.01, 
***P<0.001 as compared to control. One way anova followed by 
Dunnett’s multiple comparison test.
3.4. Alloxan induced hyperglycemia
  A single oral dose treatment of TCLE 200 mg/kg and TCLE 
400 mg/kg in hyperglycemic rats after 4 h of treatment 
caused a significant (P<0.001) decrease in blood glucose 
from 302.33 mg/dL to 192 mg/dL, and 311.17 mg/dL to 160.33 
mg/dL respectively, while glibenclamide 0.6 mg/kg p.o. 
decrease blood glucose from 313.83 mg/dL to 169.33 mg/dL 
(Figure 2). 
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Figure 2. Effect of TCLE on blood glucose level in alloxan induced 
hyperglycemic rats.
Values are expressed as mean依S.E.M.  (n=6). *P<0.05, **P<0.01, 
***P<0.001 as compared to control. One way anova followed by 
Dunnett’s multiple comparison test.
  Repeated oral dose treatment of TCLE 200 mg/kg and 
TCLE 400 mg/kg in hyperglycemic rats at 7th day caused a 
significant (P<0.001) decrease in blood glucose from 302.33 
mg/dL to 186.33 mg/dL and 311.17 mg/dL to 162.67 mg/dL 
respectively, while glibenclamide 0.6 mg/kg p.o. decrease 
blood glucose from 313.83 mg/dL to 159.5 mg/dL (Figure 
2).  TCLE 200 mg/kg and TCLE 400 mg/kg in hyperglycemic 
rats  at 14th day caused a significant (P<0.001) decrease in 
blood glucose from 302.33 to 138.5 mg/dL and 311.17 mg/dL 
to 106.5 mg/dL respectively, while glibenclamide 0.6 mg/kg 
p.o. decrease blood glucose from 313.83 mg/dL to 100.17 mg/dL
(Table 3).  
  Figure 3 & 4 reports the effect on biochemical parameters 
such as serum cholesterol and triglyceride on hyperglycemic 
rats treated with TCLE once a day for 2 weeks. TCLE 200 mg/kg
decreases cholesterol and triglyceride level 35.56% and 
21.43% respectively. TCLE 400 mg/kg decreases cholesterol 
and triglyceride level 41.76% and 28.04% respectively. 
Glibenclamide 0.6 mg/kg p.o. decreases cholesterol and 
triglyceride level 45.15% and 29.73% respectively. 
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Figure 3. Effect of TCLE on blood cholesterol level in alloxan induced 
hyperglycemic rats after 14 d treatment.
Values are expressed as mean依S.E.M.  (n=6). *P<0.05, **P<0.01, 
***P<0.001 as compared to control. One way anova followed by 
Dunnett’s multiple comparison test.
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Figure 4. Effect of TCLE on blood triglyceride level in alloxan 
induced hyperglycemic rats after 14 d treatment.
Values are expressed as mean依S.E.M.  (n=6). *P<0.05, **P<0.01, 
***P<0.001 as compared to control. One way anova followed by 
Dunnett’s multiple comparison test.
4. Discussion
  Flavonoids, sterols/triterpenoids, alkaloids and phenolics 
are known to be bioactive antihyperglycemic principles[20-23]. 
Flavonoids are known to regenerate the damaged beta cells 
in the alloxan hyperglycemic rats[9]. Phenolics are found to 
be effective antihyperglycemic agents[24-28]. Our previous 
study, we found that TCLE have very good antimicrobial and 
antioxidant activity. TCLE revealed much amount of flavonoids 
and phenolics[6].
  The present study is the preliminary assessment of the 
antihyperglycemic activity of the methanolic extract of
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T. capensis leaves. The extracts showed a dose-dependent fall 
in fasting blood sugar in alloxan induced hyperglycemic 
rats. Alloxan induces hyperglycemia by pancreatic cell 
damage mediated through generation of cytotoxic oxygen 
free radicals. The primary target of these radicals is the 
DNA of pancreatic cells causing DNA fragmentation[29]. 
The antihyperglycemic activity of TCLE may be due to its 
stimulating effect on the remnant cells or improvement in 
insulin action at cellular level or it could also be due to the 
insulin like effect of the active principle(s) present in the 
extract.
  When TCLE were administered to glucose loaded normal 
rats (OGTT) fasted for 18 h, reduction in blood glucose levels 
was observed after 60 min. The decline reached its maximum 
at 2 h compare to control. This result indicates that the 
extracts have sound capacity to block glucose absorption[28].
  In the alloxan-induced hyperglycemia in rats, the rise in 
blood glucose is accompanied by an increase in the serum 
cholesterol and triglyceride. The treatment with TCLE 
reduced cholesterol significantly in hyperglycemic rats. It 
is well known that the level of glycemic control is the major 
determinant of serum level of triglycerides[31].
  It is concluded from the data that TCLE possesses 
significant antihyperglycemic activity and it may prove to 
be effective for the treatment of hyperglycemia. However, 
longer duration studies on chronic models are necessary to 
elucidate the exact mechanism of action so as to develop it 
as a potent antihyperglycemic drug.
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